Jacobs Levy Equity Management, Inc Glaukos Corp Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Glaukos Corp stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 5,291 shares of GKOS stock, worth $439,629. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,291Holding current value
$439,629% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding GKOS
# of Institutions
334Shares Held
54.2MCall Options Held
259KPut Options Held
481K-
Black Rock Inc. New York, NY8.04MShares$668 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$508 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$270 Million0.06% of portfolio
-
State Street Corp Boston, MA2.09MShares$174 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2MShares$166 Million0.05% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $3.95B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...